Ha Yao Pharmaceutical: The current production and operation are normal, and there have been no major changes in the internal and external operating environment.

On January 6, Jin Shi Data reported that Ha Medicine Co., Ltd. issued a public announcement of abnormal stock trading Fluctuation. After self-inspection, the company’s current production and operation status is normal, and there has been no significant change in the internal and external operating environment. There are no significant matters that would affect the abnormal Fluctuation of the company’s stock trading price, and there is no significant information that should be disclosed but has not been disclosed. After confirming with the controlling shareholder, it is confirmed that the controlling shareholder of the company and all parties’ shareholders of the controlling shareholder do not have significant information that should be disclosed but has not been disclosed, which would affect the abnormal Fluctuation of the company’s stock price. The company has not found any media reports or market rumors that may have a significant impact on the company’s stock trading price.